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Abstract
Background: Hypertension is a complex disease influenced by multiple genetic and environmental factors. The
Kazakh ethnic group is characterized by a relatively high prevalence of hypertension. Previous research indicates
that the FURIN gene may play a pivotal role in the renin-angiotensin system and maintaining the sodium-
electrolyte balance. Because these systems influence blood pressure regulation, we considered FURIN as a
candidate gene for hypertension. The purpose of this study was to systematically investigate the association
between genetic variations in the FURIN gene and essential hypertension in a Xinjiang Kazakh population.
Methods: We sequenced all exons and the promoter regions of the FURIN gene in 94 hypertensive individuals to
identify genetic variations associated with the disorder. Genotyping was performed using the TaqMan polymerase
chain reaction method for four representative common single nucleotide polymorphisms (SNPs, -7315C > T, 1970C
> G, 5604C > G, 6262C > T) in 934 Kazakh Chinese people. One SNP (1970C > G) was replicated in 1,219 Uygur
Chinese people.
Results: Nine novel and seven known single nucleotide polymorphisms were identified in the FURIN gene. The
results suggest that 1970C > G was associated with a hypertension phenotype in Kazakh Chinese (additive model,
P = 0.091; dominant model, P=0.031, allele model, P = 0.030), and after adjustment with logistic regression
analysis, ORs were 1.451 (95%CI 1.106-1.905, P = 0.008) and 1.496 (95% 1.103-2.028, P = 0.01) in additive and
dominant models, respectively. In addition, the association between 1970C > G and hypertension was replicated in
Uygur subjects (additive model, P = 0.042; dominant model, P = 0.102; allele model, P = 0.027) after adjustment in
additive and dominant models, ORs were 1.327 (95% 1.07-1.646), P = 0.01 and 1.307 (95%CI 1.015-1.681, P = 0.038),
respectively. G allele carriers exhibited significant lower urinary Na
+ excretion rate than non-carriers in the Kazakh
Chinese population (152.45 ± 76.04 uM/min vs 173.33 ± 90.02 uM/min, P = 0.007).
Conclusion: Our results suggest that the FURIN gene may be a candidate gene involved in human hypertension,
and that the G allele of 1970C > G may be a modest risk factor for hypertension in Xinjiang Kazakh and Uygur
populations.
Background
Essential hypertension is considered a typical complex
disease with a multifactorial etiology, which has led to
inconsistent findings in genetic studies. A body of evi-
dence suggests that the renin-angiotensin system (RAS)
and sodium-electrolyte balance play a pivotal role in the
development and progression of hypertension.
A receptor that is specific for renin and prorenin,
named the (pro) renin receptor ([P] RR), was first iden-
tified in human mesangial cells [1]. Studies to date have
focused on the functional aspects of the protein, because
of the potential role of (P) RR in hypertension and
organ damage [2]. FURIN is an important enzyme parti-
cipating in (P) RR processing. Recently, Nguyen et al
demonstrated that FURIN, as a protease, can shed endo-
genous (P)RR [3]. Colon carcinoma cells devoid of active
FURIN were found to synthesize full-length (P)RR, but
not to secrete s(P)RR. Transfection of Chinese hamster
ovary cells with a plasmid coding for the a1-antitrypsin
Portland variant, an inhibitor of FURIN, completely
inhibited the generation of s(P)RR, whereas the addition
in the culture medium of GM6001, an inhibitor of
metalloproteases, or TNF-a protease inhibitor-1, an
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coding for (P)RR was translated in vitro and incubated
with recombinant FURIN or ADAM17, only FURIN was
found to generate the 28 kDa-s(P)RR. Moreover, muta-
genesis at the potential FURIN cleavage R275A/KT/
R278A site abolished s(P)RR generation [3].
In addition, it has been well reported that the epithe-
lial Na+ channel (ENaC) is critical for Na
+ homeostasis
and blood pressure (BP) control [4], and that defects in
ENaC function and genetic structure can cause inherited
forms of hypertension and essential hypertension [5,6].
Endothelin may participate in blood-pressure elevation
and vascular growth in moderate to severe hypertension
[7]. Furthermore, it is well established that the TGF-b
signaling pathway has a role in BP homeostasis [8].
Therefore, factors that simultaneously participate in the
regulation of function of these genes are expected to be
associated with hypertension. The proprotein processing
enzyme FURIN is the mammalian prototype of a novel
family of subtilisin-like serine endoproteases which pos-
sess cleavage specificity for sites involving multiple basic
amino acid residues and are involved in the processing
of precursor proteins of a variety of regulatory peptides
and proteins [9,10]. Recent work suggests that ENaC is
synthesized and transported from the endoplasmic reti-
culum to the Golgi apparatus in an inactive form. In the
Golgi apparatus, FURIN proteolytically cleaves specific
sites in the extracellular domains of the a-and g-subu-
nits, and this cleavage appears to activate ENaC [11]. In
addition, proendothelin-1 is subjected to proteolysis at
specific pairs of basic amino acids by FURIN, which
may also participate in the maturation of proendothelin-
1 in endothelial cells [12]. Latent TGF-b exhibits an
appropriate R-H-H-R cleavage motif and is, conse-
quently activated by FURIN [13-15]. Zacchigna et al.
reported that the extracellular protein Emilin1 inhibits
TGF-b signaling by binding specifically to the proTGF-b
precursor and preventing its maturation by FURIN in
convertases and Emilin1 knockout animals display
increased BP [16].
The human FURIN gene, consisting of sixteen exons
and fifteen introns that encode 795 amino acid residues,
is located on chromosome 15q26.1, where several loci
have shown strong or suggestive linkage to BP and
related phenotypes by genome-wide linkage scans [17].
As such, the human FURIN gene is a candidate gene
potentially underlying BP elevation.
The Xinjiang Kazakh are an ethnic minority group
with the highest prevalence of hypertension in China,
exhibiting an age-standardized prevalence of 39.8% [18].
A previous study reported that, compared with other
C h i n e s em i n o r i t ye t h n i cg r o u p si nX i n j i a n g ,t h eK a z a k h
population has a higher average salt consumption, with
a mean daily consumption of > 21 g. BP has been found
to decrease significantly after limiting salt intake [18,19].
As such, the Kazakh population is ideal for studying the
genetic factors involved in salt-sensitive hypertension.
So far, there are no reports about the relationship
between genetic variations in the human FURIN gene
and hypertension, or the genotyping of their representa-
tive variations in the general population. To address this
issue, we systemically investigated the association
between variations of the FURIN gene, hypertension and
BP in a Xinjiang Kazakh population.
Methods
Subjects
A total of 1,000 Kazakh subjects, with no miscegena-
tion, were randomly recruited for this study by multi-
stage cluster sampling from the Fukang area in the
Xinjiang Uygur Autonomous Region. Subjects with a
history of secondary hypertension, stroke, excessive
drinking, cancer and use of contraceptives were
excluded from this study. After these exclusions,
934 participants went through the survey during a
one-month period from January to February 2008.
Written consent was obtained from all subjects before
any data collection and measurement. Subjects were
divided into two groups: a hypertensive group and nor-
motensive group. We adopted the WHO’s 1999 defini-
tion of hypertension in this study: a systolic blood
pressure (SBP) of at least 140 mmHg and/or diastolic
blood pressure (DBP) of at least 90 mmHg or anti-
hypertension treatment. Non-hypertensive participants
met the following criteria: no history of any antihyper-
tensive medications, and SBP of less than 140 mmHg
and DBP of less than 90 mmHg. Diabetes mellitus
(DM) was defined by: a fasting plasma glucose level of
126 mg/dL or greater (≥ 7.0 mmol/L), or a 2-hour
postchallenge plasma glucose level of 200 mg/dL or
greater (≥ 11.1 mmol/L) or the current use of antidia-
betic medication. Hyperlipidemia was defined as total
cholesterol ≥ 220 mg/dl or triglyceride ≥ 150 mg/dl, or
t h ec u r r e n tu s eo fa n t i h y p e r lipidemia medication. BP
was measured three times in the left arm with a stan-
dard sphygmomanometer while the subject was seated
after at least 10 minutes of rest, BP measurements
were taken twice in the continuous two days. Study
subjects underwent routine laboratory tests, including
serum and urinary electrolytes, renal function, blood
glucose, total cholesterol and triglyceride. The urinary
Na
+ excretion rate (UNa
+ rate) was calculated as
UNa*UV/24 h, where UNa* was the urinary concentra-
tion of Na
+, and UV was the urinary volume in 24 h.
All clinical data, sequencing and genotyping results
were performed anonymously. The study was approved
by the Ethnics Committee of the People’sH o s p i t a l ,
Xinjiang.
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hypertension patients
We sequenced all exons and the promoter region of the
FURIN gene. Blood samples were obtained from
94 hypertensive patients, who were randomly chosen
from the hypertension group of the study population,
and genomic DNA was isolated from peripheral blood
leukocyte by using PAXgene Blood DNA Kit (PreAnaly-
tiX™). All exons with their flanking sequences and
approximately 1.0 kb of the upstream region were
directly sequenced using an ABI PRISM 3700 DNA ana-
lyzer (Applied Biosystems, Foster City, California, USA)
using twenty sets of primers as described previously [20]
(see additional file 1). The obtained sequences were
examined for the presence of variations using Sequencher
4.7 software (Gene Codes Corporation, Ann Arbor,
Michigan, USA), followed by visual inspection. The A of
the ATG of the initiator Met codon is denoted as nucleo-
tide + 1. A GenBank nucleotide sequence (accession ID
NT-010274) was used as a reference sequence.
Genotyping of representative single nucleotide
polymorphisms (SNPs) in the general population
After studying the linkage disequilibrium (LD) among
SNPs, four selected representative common SNPs, with
a minor allele frequency greater than 10%, were used to
genotype DNA samples from the study cohort. TaqMan
SNP Genotyping Assays were performed for genotyping
using the Taq amplification method in a 7900 HT Fast
Real-Time PCR system (Applied Biosystems, USA). Five
μl PCR reactions were performed using 1 μlD N A
(25 ng/μl) or H2O for negative controls, 0.125 μl probe
(20 μmol/L), and 2.25 μlM a s tM i x( 2 0μmol/l; Applied
Biosystems, USA). The reaction was cycled 43 times
with a denaturation step of 95°C for 10 seconds, an
annealing step of 60°C for 1 minute, and a final elonga-
tion step of 72°C for 7 minutes. The primers and probes
(Applied Biosystems) used in the TaqMan SNP Geno-
typing Assays were chosen based on information avail-
able on the Applied Biosystems Inc.website http://
myscience.appliedbiosystems.com. All of the four
selected representative SNPs were successfully geno-
typed in 925 subjects. For genotyping quality control,
the case and control subjects were distributed randomly
across the plates, and the samples sequenced also were
genotyped for detecting genotyping errors. The call rate
for genotyping was 98.61% and the concordance of
duplicates was 100%.
Values are expressed as means ± SD. The distribution
of patient characteristics or genotypes or allele fre-
quency of SNPs between normotensive and hypertensive
groups was analyzed using Student’s t- tests or c
2 analy-
sis. The associations of four common SNPs with hyper-
tension were analyzed using logistic regression analysis,
adjusting for age and gender. All analyses were per-
formed using the SPSS15.0. Statistical significance was
established at P < 0.05. LD and Hardy-Weinberg equili-
brium were analyzed using the SNPAlyze version 2.1
(DYNACOM Co. Ltd., Mobara, Japan).
Results
Study Population
The characteristics of the Kazakh and Uygur popula-
tions are summarized in Table 1, sorted into hyperten-
sive and normotensive groups. There were significant
differences between hypertensive and normotensive
groups in some variables, including age, BMI, SBP, DBP,
and prevalence of DM, but no significant differences
were found for gender and HDL-cholesterol between
the two groups in our two populations.
Identification of Polymorphisms and selection of
representative SNPs in FURIN
Direct sequencing using DNA samples from 94 hyper-
tension subjects revealed sixteen SNPs in the FURIN
gene, including two SNPs in the promoter region, one
SNP in the 5′-untranslated region, five synonymous
mutations in exon 13 and exon 16, four SNPs in the 3′-
untranslated region, and five SNPs in introns (Table 2).
Among these SNPs, there were six common SNPs with
a minor allele frequency over 0.05. No missense or fra-
meshift mutations were identified. Three SNPs, -7315C
> T, 4573G > T and 6262C > T, and another three
SNPs, 1970C > G, 2003T > C, and 6262C > T, were in
LD (r
2 > 0.5), respectively. Finally, four common SNPs,
-7315C > T in the promoter region, 1970C > G in
intron 7, 5604C > G in exon 16 and 6262C > T in the
3′-untranslated region, were selected for genotyping.
Association of the four representative common SNPs with
hypertension
Genotype frequencies of the four SNPs (-7315C > T,
1970C > G, 5604C > G, and 6262C > T) satisfied the
Hardy-Weinberg equilibrium both in the hypertensive
group and in the normotensive group (P > 0.05).
Table 3 shows the genotype distributions of the four
representative common SNPs between hypertensive and
normotensive groups and the replication of 1970C > G
in the Uygur population.
The present study did not find any evidence for an
association between -7315C > T, 5604C > G or 6262C >
T and hypertension. However, 1970C > G was signifi-
cantly associated with the hypertension phenotype in
Kazakh Chinese in a dominant model (P=0.031), but
n o ti na na d d i t i v em o d e l( P = 0.091). However, after
adjustment for age, gender and present ills (diabetes
mellitus and dyslipidemia) in multivariate logistic regres-
sion analysis, ORs were 1.451(95% CI 1.106-1.905),
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2.028), P = 0.01 in a dominant model. Data are shown
in Table 3. In an allele model, the allelic frequencies of
C and G were 87.37% (844) and 12.63% (122) in normo-
tensives, respectively; and 83.82% (741) and 16.18%
(143) in hypertensives, respectively. Hypertensives exhib-
ited a significantly higher allelic frequency of G (c
2 =
4.732, P = 0.030; data not shown).
In addition, we also examined hypertension and nor-
motension, defined as ≥160/100 mmHg and ≤130/80
mmHg, respectively. We found a significant association
between 1970C > G and hypertension (ORs were 1.653
[95% CI 1.1106-2.462; P = 0.013] in an additive model
and 1.854[95%CI, 1.193-2.881; P =0 . 0 0 6 ]i nad o m i n a n t
model). Data are shown in table 4.
Repetition
Genotyping with the TaqMan polymerase chain reaction
method was performed for one common SNP (1970C > G)
i nt h eg e n e r a lU y g u rp o p u l a t i o n ,w i t has a m p l es i z eo f
1,219 individuals (745 hypertensives and 474 normoten-
sives). The distribution of the genotype was significantly
different between hypertensives and normotensives in an
additive model (P = 0.042), and after adjustment for age
Table 1 Basic characteristics of subjects in hypertensives and normotensives
Characteristics Kazakh Chinese Replication(Uygur Chinese)
NT HT NT HT
Gender (men/women, n) 193/292 211/238** 165/309 261/436**
Age (years) 41.97 ± 7.44 48.40 ± 7.45* 48.03 ± 11.07 52.19 ± 10.43*
BMI (Kg/m2) 25.05 ± 3.48 28.68 ± 4.40* 26.39 ± 4.28 27.40 ± 4.56*
SBP (mmHg) 114.61 ± 8.92 165.05 ± 22.88* 111.37 ± 11.52 142.86 ± 28.35*
DBP (mmHg) 76.13 ± 6.27 104.63 ± 12.05* 69.19 ± 8.7 84.83 ± 16.76*
Total cholesterol (mmol/L) 4.88 ± 1.04 5.12 ± 1.01* 4.33 ± 1.19 4.55 ± 1.24*
HDL-cholesterol (mmol/L) 1.47 ± 0.39 1.46 ± 0.43* 1.09 ± 0.34 1.09 ± 0.32
LDL-cholesterol (mmol/L) 2.92 ± 0.79 3.11 ± .079* 2.41 ± 1.04 2.63 ± 1.12*
Triglyceride (mmol/L) 0.99 ± 0.55 1.30 ± 0.83* 1.43 ± 0.89 1.72 ± 1.43*
Fasting glucose (mmol/L) 4.85 ± 0.56 5.42 ± 0.69* 5.42 ± 1.84 6.0 ± 2.79*
Diabetes mellitus(%) 4.90 2.01** 14.9 25.1**
NT, normotensives; HT, hypertensives; BMI, body mass index; SBP, systolic blood pressure; DBP, diatolic blood pressure. Data are mean ± std or percentage.
P values were analyzed using Student’s t- test. Diabetes, fasting plasma glucose 6.0 mmol/l or greater or non-fasting plasma glucose level of 11.1 mmol/l or
greater, or antidiabetic Medication.;*P < 0.05 between normotensives and hypertensives by t-test; **P < 0.05 between normotensives and hypertensives by
c
2 test.
Table 2 Sequence variations in the promoter region and exons in Furin identified in Kazakhs hypertensive patients
SNP name LD Region Aminoacid substitution Allele 1 freq Allele 2 freq Flanking sequence Typing db SNP ID
-7393C > G promoter 0.9884 0.0116 acacaaggag[c/g]tggagctggc
-7315C > A a promoter 0.7733 0.2267 aagtgcagac[c/a]caccccaata TaqMan rs4932178
-7048T > C 5’-UTR 0.9942 0.0057 tcccaggtgc[t/c]ctggagctgg
1970C > G b intron7 0.8046 0.1954 gccactttcc[c/g]actgtggatc TaqMan rs2071410
2000G > C intron7 0.9942 0.0058 gaaagagctg[g/c]acccctgtgg
2003T > C b intron7 0.8081 0.1919 ggctgttcca[t/c]ggagggttcc rs1573643
2589C > T intron8 0.9945 0.0055 tgtccagccc[c/t]tgcgggcagg
4369G > T exon13 R464R 0.9940 0.0060 tcgggaaacg[g/t]ctcgaggtgc rs6225
4393C > T exon13 T472T 0.9759 0.0241 agaccgtgac[c/t]gcgtgcctgg
4573G > T a intron13 0.7590 0.2410 cagcgccgcc[g/t]cctctcacag rs6224
5604G > C exon16 G617G 0.4048 0.5952 gccctccagg[g/c]ttcgcccccc TaqMan rs6226
6123C > T exon16 D770D 0.9943 0.0057 ttatcaaaga[c/t]cagagcgccc
6262C > T a 3’-UTR 0.7989 0.2011 gtggagactg[c/t]ttcccatcct TaqMan rs6227
6563G > T 3’-UTR 0.9943 0.0057 tgagggagga[g/t]gccacctctc
6624C > T 3’-UTR 0.9886 0.0114 tgagtcttgg[c/t]ggcagcagcc
6728C > T 3’-UTR 0.9943 0.0057 ccctgtgctc[c/t]gtgcctccac
The apparent linkage disequilibrium (LD), defined by r-square more than 0.5, was indicated by a-b in the LD column. Taqman, The single nucleotide
polymorphism (SNP) was successfully genotyped by the Taqman method. UTR, Untranslated region. The A of the ATG of the initiator Met codon is denoted
nucleotide +1, as recommended by the Nomenclature Working Group (Hum Mut 1998; 11:1-3). The nucleotide sequence (GenBank Accession ID: NT-010274) was
used as a reference sequence.
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(95%CI 1.07-1.646; P = 0.01). Although in a dominant
model, the genotype distribution was not significantly dif-
ferent (P = 0.102), the adjusted OR was 1.307(95%CI
1.015-1.681), P = 0.038. In an allele model, the hypertensive
group had a significantly higher allelic frequency of G (c
2 =
4.886, P = 0.027). This finding is consistent with the results
found in the Kazakh population.
Table 3 Distribution of Genotypes for Furin Variable in Hypertensives and Normotensives
Population Variants Genotypes NT HT Additive model c
2 P
n(%) n(%) OR(95%CI)
CC 315(65.6) 290(65.3)
CT 143(29.8) 134(30.2) 1.1 (0.87-1.391) 0.018 0.991*
-7315C > T TT 22(4.8) 20(4.5) 0.424†
rs4932178
CC CT+TT 315(65.6) 290(65.3) 0.01 0.921*
165(34.6) 154 (34.7) 1.132 (0.853-1.503) 0.391†
GG 171(35.7) 145(30.27)
5604G > C GC 239(49.9) 219(45.72) 1.084 (0.891-1.319) 2.286 0.319*
rs6226 CC 69(14.41) 79(16.49) 0.42†
Kazakh Chinese CG CG+GG 171(35.7) 145(30.27) 1.031 (0.776-1.369) 0.9 0.343*
308(50.1) 298(46.76) 0.834†
CC 362(74.9) 322(72)
6262C > T CT 113(23.4) 113(25.3) 1.284 (0.981-1.681) 1.748 0.417*
rs6227 TT 8(1.7) 12(2.7) 0.69†
CT vs CT+TT 362(74.9) 322(72) 1.28 (0.945-1.733) 1.012 0.313*
121(25.1) 125(28) 0.111†
CC 369(76.4) 310(45.7)
1970C > G CG 106(21.9) 121(27.4) 1.451 (1.106-1.905) 4.784 0.091*
rs2071410 GG 8(1.7) 11(2.5) 0.008†
CG vs CG+GG 369(76.4) 310(45.7) 1.496 (1.103-2.028) 4.636 0.031*
114(22.6) 132(29.9) 0.01†
CC 322(67.9) 472(63.4)
Replication (Uygur Chinese) 1970C > G CG 140(29.5) 234(31.4) 1.327 (1.07-1.646) 6.323 0.042*
rs2071410 GG 12(2.5) 39(5.2) 0.01†
CG vs CG+GG 322(67.9) 472(63.4) 1.307 (1.015-1.681) 2.672 0.102*
160(32) 273(36.6) 0.038†
NT, normotensives; HT, hypertensives. In the additive model, odds ratios (ORs) were expressed per difference in number of minor alleles. In the dominant model,
ORs were shown as heterozygotes and minor allele homozygotes compared with major allele homozygotes.*P was caculated by c
2 test; †P and ORs were
caculated by mutivariable logistic regression analysis after adjustment for gender, age and present ills(dibetes mellitus and dyslipidemia)
Table 4 Distribution of Genotypes for 1970C > G in subgroups in Kazakh Chinese
Polymorphisms Genotypes Subgroup1 Subgroup 2 OR(95%CI) c
2 P
n(%) n(%)
1970C > G CC 311(76.0) 112(67.5) 5.715 0.057*
CG 90(22.0) 52(31.3) 1.653 (1.11-2.462) 0.013†
(rs2071410) GG 8(2.0) 2(1.2)
CC 311(76.0) 112(67.5) 1.854 (1.193-2.881) 4.459 0.035*
CG+GG 98(24.0) 52(32.5) 0.006†
Subgroup 1, defined as systolic blood pressure ≤ 130 mmHg, and diabolic blood pressure ≤ 80 mmHg; Subgroup 2, defined as systolic blood pressure ≥ 160
mmHg, and diabolic blood pressure ≥ 100 mmHg. *, calculated by c
2 test; †, ORs are calculated by Logistic regression analysis.
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excretion rate between different genotypes by covariate
variance analysis, adjusting for gender, age and present
ills (diabetes mellitus and dyslipidemia). For Kazakh
Chinese, the Urinary Na
+ excretion rate was significantly
lower for CC than CC+CT individuals (P =0 . 0 0 7 ) .
However, there was no significant difference between
genotypes in the Uygur Chinese population (P = 0.464).
Discussion
The present study is the first to examine the relation-
ships between genetic variations in the FURIN gene and
hypertension in humans. By systemically screening varia-
tions of FURIN and studying the associations of four
representative common SNPs with hypertension, and we
did not identify any rare functional mutations in the
functional regions of FURIN. However, the data indi-
cated possible associations between the common SNP
1970C > G and hypertension, and this was replicated in
the general Uygur population. These findings indicate
that the FURIN gene may be a candidate gene involved
in human hypertension, and that G allele of 1970C > G
may be a modest risk factor for hypertension.
Hypertension, as a complex trait, has been suggested
to be caused by common sequence variants that may
have a small to moderate phenotypic effect [21,22]. On
the other hand, some studies have shown that most
Mendelian disorders are caused by a set of different rare
mutations that reside in coding regions, which tend to
have strong phenotypic effects. Several recent studies
have shown that rare genetic variations in ABCA1,
APOA1, and LCAT, collectivelyc o n t r i b u t et ov a r i a t i o n
in plasma levels of HDL-cholesterol in the general
population [23-25]. As such, we hypothesize that both
common rare genetic variations in the FURIN gene may
contribute to hypertension. In this study, we systemi-
cally investigated the association between genetic varia-
tions of the FURIN gene and hypertension in a Xinjiang
Kazakh population by screening genetic variations of the
FURIN gene, then examining the relations between the
representative SNPs and hypertension. This research
strategy was selected for the following reasons: a) Hap-
Map project does not provide genetic information for
Xinjiang Kazakhs. In the HapMap database, the minor
allelic frequencies of rs4932178, rs6226, rs6227 and
rs2071410 are different among different ethnic groups
(CEU:38.5%, 0%, 38.3% and 39%; CHB:16.7%, 5%, 4.40%
and 4.44%; JPT: 14%, 4%, 9.1% and 10.2%; YRI:32.7%,
0%, 26.7% and 14.2%, compared to Xinjiang Kazakh
[from the present results]: 19.53%, 40.89%, 14.30% and
14.32%, respectively). Thus, the genotype frequencies of
common SNPs in the Kazakh population differ from
those in the other ethnic groups. As such, we could not
use the Tag-SNP specific for Kazakhs in this study. b)
By sequencing the functional regions of the FURIN gene
in 94 Kazakh hypertensives, we were able to find com-
mon and rare SNPs or mutations, both of which are
considered to contribute to the pathogenesis of
hypertension.
In this study, we did not find any missense/frameshift
mutations in the FURIN gene. This may be indicative of
the relatively high conservation of the FURIN gene and
the importance of this molecule in regulating BP. A sig-
nificant association between the common SNP 1970C >
G and hypertension was obtained in our multivariable
analysis with adjustment for age and gender. In the pre-
sent study, we genotyped four SNPs that are not in a
tight LD. Thus, it is necessary to perform a correction
for multiple testing. After correcting with the Bonferroni
method, no SNPs were significantly associated with
hypertension. However, a possible association of 1970C
> G with hypertension was re-confirmed in the general
Xinjiang Uygur population, and the G allele carriers
exhibited a significantly lower urinary Na
+ excretion
rate in Kazakh Chinese people. Because the Kazakh
population consumes an extremely high amount of salt,
we defined hypertension and normotension as ≥ 160/
100 mmHg and ≤ 130/80 mmHg, respectively, to reduce
the possibility of misclassification. A significant associa-
tion remained between 1970C > G and hypertension in
subgroups (P < 0.05). Moreover, distribution of all poly-
morphisms conformed to the Hardy-Weinberg equili-
brium, suggesting that the results of this study are
unlikely to have been biased by population stratification
or admixture for essential hypertension. All of these
findings indicate that our results are likely to be reliable.
The mechanisms by which the common SNP 1970C >
G might contribute to hypertension are currently
unknown. 1970C > G is located in an intronic region. It
has traditionally been assumed that the sequence of any
given intron is junk DNA with no biological function.
More recently, however, this notion has been disputed
Table 5 Comparing of urinary Na+ excretion rate
between different genotypes
Population 1970C > G P
value
non-carrier carrier
UNa
+ rate (uM/
min)
n = 549 n = 195
Kazakh
Chinese
173.33 ±
90.02
152.45 ±
76.04
0.007*
n = 599 n = 308
Uygur
Chinese
140.21 ±
79.80
144.52 ±
89.10
0.464*
UNa
+ rate, Urinary Na+ excretion rate; All the skew datas were transformed by
logarithm. *P was calculated by Covariate variance analysis after adjustment
for gender age and present ills(diabetes mellitus and dyslipidemia).
Li et al. BMC Medical Genetics 2010, 11:124
http://www.biomedcentral.com/1471-2350/11/124
Page 6 of 7[26]. Introns contain several short sequences that are
important for efficient splicing, such as acceptor and
donor sites at either end of the intron as well as a
branch point site, which are required for proper splicing
by the spliceosome. Therefore, further investigation is
necessary to determine whether the polymorphisms of
1970C > G affect the splicing of mRNA of the FURIN
gene. In addition, it remains possible that 1970C > G is
am e r eg e n e t i cm a r k e r ,a n di tm a yb et h a tL Dw i t h
other functional variations within the FURIN gene and
other functional polymorphisms play more important
roles in hypertension. A greater density of genotyping
around the FURIN gene or 1970C > G site is needed to
address these issues.
Conclusion
In summary, our results indicate that the G allele of
1970C > G in the FURIN gene may be an independent
risk factor for hypertension. We propose that genetic
variations of the FURIN gene collectively contribute to
the pathogenesis of hypertension in the Xinjiang Kazakh
and Uygur populations.
Additional material
Additional file 1: Primers for polymerase chain reaction (PCR) and
sequencing for Furin gene. Aditional file 1 showed the information on
primers for polymerase chain reaction and sequencing
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